TECON BIOLOGY Co.LTD Balance Sheet

Financials in millions CNY. Fiscal year is January - December.

Millions CNY. Fiscal year is Jan - Dec.

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Mar '26 Mar 31, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Jan '23 Jan 1, 2023	Jan '22 Jan 1, 2022
Cash & Equivalents	2,831	2,081	3,102	2,822	3,320	3,424
Trading Asset Securities	426.28	349.97	5.52	0.47	650.94	-
Cash & Short-Term Investments	3,257	2,431	3,107	2,822	3,970	3,424
Cash Growth	-0.41%	-21.78%	10.11%	-28.92%	15.96%	64.03%
Accounts Receivable	628.11	450.22	534.08	444.28	401.82	314.58
Other Receivables	248.43	170.25	396.56	425.39	464.03	437.5
Receivables	876.55	620.47	943.13	889.67	885.44	771.88
Inventory	5,345	5,565	4,594	4,554	6,042	5,251
Prepaid Expenses	-	-	-	-	-	5.37
Other Current Assets	1,311	1,333	1,204	695.1	1,498	1,160
Total Current Assets	10,789	9,950	9,848	8,961	12,396	10,612
Property, Plant & Equipment	6,557	6,715	6,975	7,093	6,453	6,081
Long-Term Investments	15.94	16.52	33.29	36.11	105.45	108.07
Goodwill	165.82	165.82	165.82	178.48	22.24	22.24
Other Intangible Assets	362.34	363.78	377.17	360.84	268.4	272.11
Long-Term Deferred Tax Assets	115.6	112.25	99.14	72.18	39.54	16.06
Long-Term Deferred Charges	27.97	29	26.48	31.05	30.83	26.17
Other Long-Term Assets	9.23	39.17	38.22	19.34	46.9	1.28
Total Assets	18,043	17,391	17,563	16,752	19,362	17,139
Accounts Payable	714.83	601.58	611.86	697.12	611.11	465.23
Accrued Expenses	196.89	172.98	364.43	411.89	405.67	436.52
Short-Term Debt	2,860	3,114	3,233	3,319	3,215	4,039
Current Portion of Long-Term Debt	922.21	1,066	739.8	1,366	624.37	676.7
Current Portion of Leases	-	-	126.1	122.77	102.31	64.85
Current Income Taxes Payable	31.54	19.96	11.68	16.83	11.23	8.27
Current Unearned Revenue	1,044	802.88	669.11	444.63	476.32	686.52
Other Current Liabilities	834.49	717.77	738.56	708.94	762.53	594.67
Total Current Liabilities	6,604	6,495	6,495	7,087	6,208	6,971
Long-Term Debt	2,552	1,876	2,057	1,225	3,133	2,059
Long-Term Leases	278.09	313.04	322.12	362.93	302.53	294.58
Long-Term Unearned Revenue	150.43	152.94	144.58	143.29	87.51	81.02
Long-Term Deferred Tax Liabilities	17.68	18.08	17.62	18.13	1.45	0.75
Other Long-Term Liabilities	0.09	0.09	6.42	-	-	-
Total Liabilities	9,602	8,854	9,043	8,837	9,733	9,406
Common Stock	1,365	1,365	1,365	1,365	1,354	1,354
Additional Paid-In Capital	3,945	3,945	3,942	3,942	3,842	3,303
Retained Earnings	1,400	1,563	1,657	1,052	2,713	2,447
Comprehensive Income & Other	148.48	67.51	51.06	51.12	5.03	-5.4
Total Common Equity	6,859	6,941	7,016	6,411	7,915	7,098
Minority Interest	1,583	1,595	1,504	1,504	1,715	634.88
Shareholders' Equity	8,442	8,537	8,520	7,915	9,630	7,733
Total Liabilities & Equity	18,043	17,391	17,563	16,752	19,362	17,139
Total Debt	6,611	6,368	6,479	6,396	7,377	7,133
Net Cash (Debt)	-3,354	-3,938	-3,371	-3,574	-3,406	-3,709
Net Cash Per Share	-2.38	-2.80	-2.45	-2.65	-2.55	-3.38
Filing Date Shares Outstanding	1,361	1,499	1,365	1,365	1,354	1,354
Total Common Shares Outstanding	1,361	1,499	1,365	1,365	1,354	1,354
Working Capital	4,186	3,455	3,353	1,874	6,188	3,641
Book Value Per Share	5.04	4.63	5.14	4.70	5.84	5.24
Tangible Book Value	6,331	6,412	6,473	5,871	7,625	6,803
Tangible Book Value Per Share	4.65	4.28	4.74	4.30	5.63	5.03
Buildings	-	-	5,237	4,664	4,183	3,541
Machinery	-	-	3,992	3,499	3,206	2,626
Construction In Progress	-	-	233.09	814.7	425.14	894.54

Source: S&P Global Market Intelligence. Standard template. Financial Sources.